Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q2 2022
Institutional positions in Calidi Biotherapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +2 vs. Q1 2022
- Shares held
- 21.7M
- +1.24M (+6.0%) vs. Q1 2022
- Total value
- $214.8M
- +$12.4M (+6.1%) vs. Q1 2022
- New holders
- 5
- 12 more added
- Sold out
- 3
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 2,270,673 | $22.6M | 0.29% | +290,673+14.7% | Added |
| Woodline Partners LP | 1,980,000 | $19.7M | 0.32% | 00.0% | Unchanged |
| Nomura Holdings Inc | 1,871,272 | $18.6M | 0.08% | +1,685,636+908.0% | Added |
| Driehaus Capital Management LLC | 1,500,000 | $14.9M | 0.24% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 1,400,000 | $13.9M | 0.34% | +229,325+19.6% | Added |
| 683 Capital Management, LLC | 1,200,000 | $11.9M | 0.86% | 00.0% | Unchanged |
| Apollo Management Holdings, L.P. | 1,188,000 | $11.8M | 0.09% | −747,454−38.6% | Reduced |
| Marshall Wace, LLP | 1,062,226 | $10.6M | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 1,046,101 | $10.4M | 0.01% | +551,300+111.4% | Added |
| Governors Lane LP | 1,000,000 | $9.94M | 0.84% | 00.0% | Unchanged |
| Aristeia Capital LLC | 990,000 | $9.84M | 0.18% | 00.0% | Unchanged |
| Periscope Capital Inc. | 964,081 | $9.58M | 0.26% | +236,865+32.6% | Added |
| D. E. Shaw & Co., Inc. | 820,025 | $8.15M | 0.01% | +2500.0% | Added |
| Sculptor Capital LP | 764,600 | $7.60M | 0.08% | +264,600+52.9% | Added |
| Saba Capital Management, L.P. | 621,500 | $6.18M | 0.08% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 400,580 | $3.98M | 0.09% | +1000.0% | Added |
| Wolverine Asset Management LLC | 327,386 | $3.25M | 0.04% | +883+0.3% | Added |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 300,000 | $2.98M | 0.04% | 00.0% | Unchanged |
| Parallax Volatility Advisers, L.P. | 254,044 | $2.52M | 0.01% | +254,044 | New |
| Berkley W R Corp | 235,621 | $2.34M | 0.12% | 00.0% | Unchanged |
| Centiva Capital, LP | 199,996 | $1.99M | 0.11% | +25,976+14.9% | Added |
| Rpo LLC | 173,483 | $1.73M | 0.47% | −909−0.5% | Reduced |
| Blackstone Group Inc. | 170,842 | $1.70M | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 126,349 | $1.26M | 0.00% | −727−0.6% | Reduced |
| Highbridge Capital Management LLC | 125,000 | $1.24M | 0.03% | −434,179−77.6% | Reduced |
| Bank of Montreal | 100,000 | $995.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 100,000 | $994.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 86,493 | $860.0K | 0.03% | −705−0.8% | Reduced |
| Linden Advisors LP | 50,000 | $497.0K | 0.00% | 00.0% | Unchanged |
| Segantii Capital Management Ltd | 50,000 | $497.0K | 0.01% | 00.0% | Unchanged |
| CNH Partners LLC | 40,584 | $403.0K | 0.01% | 00.0% | Unchanged |
| Elequin Capital LP | 40,000 | $398.0K | 0.09% | +40,000 | New |
| Kohlberg Kravis Roberts & Co. L.P. | 35,317 | $351.0K | 0.00% | 00.0% | Unchanged |
| Arena Investors LP | 35,123 | $349.0K | 0.16% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 32,380 | $322.0K | 0.02% | −27,720−46.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 27,520 | $274.0K | 0.00% | +200+0.7% | Added |
| Old Mission Capital LLC | 18,665 | $186.0K | 0.01% | −8,110−30.3% | Reduced |
| Dark Forest Capital Management LP | 2,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,588 | $16.0K | 0.00% | +41+2.7% | Added |
| Cohen & Co Financial Management, LLC | 31,767 | $3.00K | 0.00% | +31,767 | New |
| Clear Street LLC | 100 | $1.00K | 0.00% | +100 | New |
| Magnetar Financial LLC | 63,132 | $0 | 0.00% | +63,132 | New |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −1,159,998−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −57,000−100.0% | Sold out |
| Cohanzick Management, LLC | 0 | $0 | 0.00% | −2,550−100.0% | Sold out |